| Shauna Gagner, MD | |
|
2075 N 1200 W, Layton, UT 84041-1616 | |
| (801) 779-6200 | |
| (801) 779-6294 |
| Full Name | Shauna Gagner |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 2075 N 1200 W, Layton, Utah |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437206398 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 7036801-1205 (Utah) | Primary |
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942325154 PECOS PAC ID: 1850209420 Enrollment ID: O20080610000303 |
News Archive
Why have large outbreaks of Ebola virus killed tens of thousands of gorillas and chimpanzees over the last decade? Observations published in the May issue of The American Naturalist provide new clues, suggesting that outbreaks may be amplified by Ebola transmission between ape social groups.
Kaiser Health News staff writer Jessica Marcy talks with Dr. Antonio Falcon, a physician in the border town of Rio Grande City, Texas. He explained his concern "about several health threats facing border communities, including tuberculosis, diabetes, obesity and the H1N1 virus that causes swine flu."
Aetna President Mark Bertolini said Wednesday that his company has seen much slower sales of national insurance accounts where large employers pay Aetna to administer plans for employees, The Associated Press reports. Under the new health overhaul, Bertolini said he expected less movement in that market because of the uncertainty in the law.
Immune Targeting Systems (ITS) Limited, one of the leading developers of synthetic vaccines for mutating viruses, today announced the first patient has been treated in its Phase-I trial with its synthetic universal influenza vaccine (FP-01). Commencement of trials follows receipt of UK Regulatory Authority (MHRA) approval. Over the same period the company brought in £500,000 new investment from Esperante Ventures (UK).
The widely prescribed statin, simvastatin, can medically help patients with secondary progressive Multiple Sclerosis - for reasons that might be unrelated to the drug's intended cholesterol lowering affects, a UCL study has found.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shauna Gagner, MD Po Box 27128, Salt Lake City, UT 84127-0128 Ph: (801) 779-6200 | Shauna Gagner, MD 2075 N 1200 W, Layton, UT 84041-1616 Ph: (801) 779-6200 |
News Archive
Why have large outbreaks of Ebola virus killed tens of thousands of gorillas and chimpanzees over the last decade? Observations published in the May issue of The American Naturalist provide new clues, suggesting that outbreaks may be amplified by Ebola transmission between ape social groups.
Kaiser Health News staff writer Jessica Marcy talks with Dr. Antonio Falcon, a physician in the border town of Rio Grande City, Texas. He explained his concern "about several health threats facing border communities, including tuberculosis, diabetes, obesity and the H1N1 virus that causes swine flu."
Aetna President Mark Bertolini said Wednesday that his company has seen much slower sales of national insurance accounts where large employers pay Aetna to administer plans for employees, The Associated Press reports. Under the new health overhaul, Bertolini said he expected less movement in that market because of the uncertainty in the law.
Immune Targeting Systems (ITS) Limited, one of the leading developers of synthetic vaccines for mutating viruses, today announced the first patient has been treated in its Phase-I trial with its synthetic universal influenza vaccine (FP-01). Commencement of trials follows receipt of UK Regulatory Authority (MHRA) approval. Over the same period the company brought in £500,000 new investment from Esperante Ventures (UK).
The widely prescribed statin, simvastatin, can medically help patients with secondary progressive Multiple Sclerosis - for reasons that might be unrelated to the drug's intended cholesterol lowering affects, a UCL study has found.
› Verified 2 days ago
Michael Patrick Husseman, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2084 N 1700 W, Suite A, Layton, UT 84041 Phone: 801-773-8644 Fax: 801-773-9828 | |
Joshua Mcbride, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2075 University Park Blvd, Layton, UT 84041 Phone: 801-779-6200 | |
Jennifer M Gilsoul, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2084 N 1700 W, Suite A, Layton, UT 84041 Phone: 801-773-8644 Fax: 801-773-9828 | |
Colton Lee Ragsdale, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2084 N 1700 W, Suite A, Layton, UT 84041 Phone: 801-773-8644 Fax: 801-927-1591 | |
Frank D Kramer, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2121 N 1700 W, Layton, UT 84041 Phone: 801-773-4840 Fax: 801-525-8151 | |
Dr. Mari Suto Luce, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2244 E 3500 N, Layton, UT 84040 Phone: 801-387-4500 | |
Steven Jonathan Williams, Pediatrics Medicare: Medicare Enrolled Practice Location: 3225 W Gordon Ave Ste 1, Layton, UT 84041 Phone: 801-397-6150 |